Breath Therapeutics is a startup based in Germany, most recent round Acquired.
Breath Therapeutics is a company founded in 2017 headquartered in Germany. Breath Therapeutics has been acquired.
Breath Therapeutics is a biopharmaceutical company developing drug-aerosol therapeutics for rare pulmonary diseases, focusing on a proprietary nebulized cyclosporine A treatment for Bronchiolitis Obliterans Syndrome in lung transplant patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.